头盔-CPAP在轻度至中度的冠状病毒2型低氧症中的有效性:一项观察性研究
Aurio Fajardo-Campoverdi1, Juan José Orellana-Cáceres2, Vicente Fernández3
1Universidad de la Frontera, Critical Care Unit, Hospital Biprovincial Quillota-Petorca, Chile.
Medicina intensiva
|March 27, 2024
概括
在COVID-19患者中,头盔CPAP显著降低了91%的输管风险,与高流量鼻氧疗法相比. 虽然使用头盔CPAP观察到死亡风险降低,但它在统计学上并不显著.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 非侵入性通风策略对于管理COVID-19患者的低氧症至关重要.
- 将不同氧化支持方法的有效性进行比较对于优化患者的治疗结果至关重要.
- 头盔CPAP和高流量鼻氧疗法是对轻度至中度低氧症的常见干预措施.
研究的目的:
- 为了比较头盔CPAP (H_CPAP) 与高流量鼻氧疗法 (HFNO) 在预防输管或死亡方面的疗效.
- 为了评估这些干预措施的成年患者,由于COVID-19的轻度至中度低氧化症.
- 评估在重症监护室以外的中等复杂度医院环境中的相对有效性.
主要方法:
- 在一个单一的中心进行了队列分析研究.
- 包括由COVID-19引起的轻度至中度低氧症的成年患者.
- 测量结果包括输管的需要和死亡率,比较H_CPAP与HFNO.
主要成果:
- 该研究包括159名患者,H_CPAP与HFNO支持的比例为2:10.
- 与HFNO (42.1%) 相比,H_CPAP (3.8%) 的输管风险明显较低,风险降低了91% (p < 0.01).
- 虽然H_CPAP显示了降低死亡率的趋势 (79.1%的风险降低),但它没有达到统计学意义 (p = 0.11).
结论:
- 头盔CPAP是一种有效的呼吸系统支持策略,用于减少非ICU COVID-19患者的输管风险,这些患者有轻度至中度的低氧化症.
- 与H_CPAP相比,HFNO与输管风险更高相关.
- 由于各组患者特征 (年龄,严重程度) 的差异,他们注意到了潜在的偏见.
相关概念视频
Mechanical Ventilation III: Noninvasive Ventilation
111
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
111
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
206
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
206
Acute Respiratory Failure-II
222
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
222
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Oxygen Delivering System I: Nasal Cannula and Face Mask
304
The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
304
Acute Respiratory Failure-I
204
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
204


